MNV-BLD

N/A

Report date: 2025/05/22 16:59:59

Base Information

Drug NameMNV-BLD

Drug Alias NameCD34+ cells enriched with MNVBLDMitochondrial cell therapyAutologous CD34+ cells enriched with blood-derived mitochondriaMNV-BLDMNV-BM-BLD +[6]

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsMitochondrial DiseasesPearson syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMinovia Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMinovia Therapeutics Ltd

Inactive CompaniesN/A

Active IndicationsMitochondrial DiseasesPearson syndrome

Inactive IndicationsN/A

Other Information

ATC CodeN/A